Stratasys Ltd. (NASDAQ:SSYS) Short Interest Down 19.5% in December

Stratasys Ltd. (NASDAQ:SSYS - Get Free Report) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 746,000 shares, a drop of 19.5% from the November 30th total of 927,200 shares. Based on an average trading volume of 624,400 shares, the short-interest ratio is currently 1.2 days. Currently, 1.3% of the shares of the company are sold short.

Institutional Trading of Stratasys

Several institutional investors have recently modified their holdings of the stock. Invenomic Capital Management LP acquired a new stake in shares of Stratasys in the third quarter worth approximately $10,916,000. Clearline Capital LP purchased a new position in Stratasys in the 2nd quarter valued at $9,301,000. Rubric Capital Management LP boosted its stake in Stratasys by 18.2% during the 2nd quarter. Rubric Capital Management LP now owns 5,968,703 shares of the technology company's stock worth $50,077,000 after purchasing an additional 918,703 shares during the last quarter. RPG Investment Advisory LLC grew its holdings in shares of Stratasys by 29.6% during the third quarter. RPG Investment Advisory LLC now owns 659,996 shares of the technology company's stock worth $5,485,000 after buying an additional 150,891 shares in the last quarter. Finally, RBF Capital LLC purchased a new stake in shares of Stratasys during the third quarter worth $1,080,000. Institutional investors and hedge funds own 75.77% of the company's stock.

Stratasys Stock Down 2.2 %

Shares of SSYS stock traded down $0.21 during mid-day trading on Friday, hitting $9.15. 296,679 shares of the stock were exchanged, compared to its average volume of 523,557. Stratasys has a 52-week low of $6.05 and a 52-week high of $14.65. The company has a market cap of $653.11 million, a PE ratio of -6.93 and a beta of 1.31. The firm has a fifty day moving average of $8.94 and a 200 day moving average of $8.25.

Stratasys (NASDAQ:SSYS - Get Free Report) last issued its quarterly earnings results on Wednesday, November 13th. The technology company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. The company had revenue of $140.00 million for the quarter, compared to the consensus estimate of $139.49 million. Stratasys had a negative return on equity of 3.75% and a negative net margin of 16.13%. Stratasys's revenue for the quarter was down 13.6% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.05) earnings per share. Equities analysts predict that Stratasys will post -0.4 EPS for the current year.

Wall Street Analysts Forecast Growth

SSYS has been the topic of a number of research reports. Needham & Company LLC increased their price objective on Stratasys from $10.00 to $12.00 and gave the company a "buy" rating in a report on Thursday, November 14th. Craig Hallum lifted their price objective on shares of Stratasys from $12.00 to $15.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Loop Capital reduced their target price on shares of Stratasys from $9.00 to $7.00 and set a "hold" rating for the company in a report on Thursday, September 5th. Finally, StockNews.com raised shares of Stratasys from a "hold" rating to a "buy" rating in a report on Wednesday. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $11.40.

About Stratasys

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and selective absorption fusion printer for additive manufacturing, and tooling and rapid prototyping for various vertical markets, such as automotive, aerospace, consumer products and healthcare.